Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lukusa AK et al. - With regard to HU, semen impairment appears to be related to the duration of treatment. To draw general conclusions, further research with a large number of patients treated since childhood with HU or HSCT is warranted.

Related Articles

Vaccines for preventing invasive salmonella infections in people with sickle cell disease
Cochrane Reviews, 10/23/09    Relevance Score: 82%

Study Targets Stroke Prevention in Children With Sickle Cell Anemia
Internet Source, 10/30/09    Relevance Score: 81%

Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case—control study
The Lancet, 10/20/09    Relevance Score: 81%

Severe sickle cell disease – pathophysiology and therapy
Biology of Blood and Marrow Transplantation, 10/15/09    Relevance Score: 81%

Investigational drugs in sickle cell anemia
Expert Opinion on Investigational Drugs, 10/05/09    Relevance Score: 80%

Today in Coagulation/Bleeding Dz...keeping you current

Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis
Seminars in Thrombosis and Hemostasis, 12/15/09

Particulate Air Pollution and Cardiovascular Risk: Short-term and Long-term Effects
Seminars in Thrombosis and Hemostasis, 12/15/09

Polycystic Ovarian Syndrome and the Risk of Cardiovascular Disease and Thrombosis
Seminars in Thrombosis and Hemostasis, 12/15/09